UroGen Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
URGN Key Statistics
Stock Snapshot
The current UroGen Pharma(URGN) stock price is $18.74, with a market capitalization of 877.2M. The stock trades at a price-to-earnings (P/E) ratio of -5.41.
During the trading day, UroGen Pharma(URGN) stock saw an opening price of $19.39, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 700.09K.
The stock's 52-week range extends from a low of $3.42 to a high of $30.00.
The stock's 52-week range extends from a low of $3.42 to a high of $30.00.
URGN News
Urogen Pharma (URGN) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing too...
UroGen Pharma (URGN) shares are in focus after the company reported that its bladder cancer therapy ZUSDURI now has a permanent J code (J9282), effective Januar...
